Cytokine 25-Plex Human Panel
Cytokine 25-Plex Human Panel
Invitrogen™

Cytokine 25-Plex Human Panel

The Cytokine Human Magnetic 25-Plex Panel for the Luminex™ platform is specifically designed for quantifying human cytokines and chemokines in深入閱讀
Have Questions?
產品號碼Quantity
LHC0009M96 Tests
產品號碼 LHC0009M
價格 (TWD)
-
申請報價
Quantity:
96 Tests
The Cytokine Human Magnetic 25-Plex Panel for the Luminex™ platform is specifically designed for quantifying human cytokines and chemokines in serum, plasma, and tissue culture supernatant. By measuring 25 analytes simultaneously, the Luminex™ assay panel helps provide more data from each sample, saving both money and time compared to more traditional systems (such as ELISA) used in research. This assay may be run alone or in combination with other select Luminex™ singleplex kits. The panel uses magnetic beads, facilitating automation, decreasing hands-on time, and increasing throughput and precision. The panel is suitable for use with the Luminex™ 100™/200™, FLEXMAP 3D™, and MAGPIX™ systems. Advantages of the Cytokine Human Magnetic 25-Plex Panel:

Superior performance—accurate, reproducible, and sensitive quantitation of multiple proteins
High quality—fully qualified antibodies permit excellent specificity and sensitivity
Fast and easy protocols—perform your multiplex assay and analyze your data typically in less than one day

Comprehensive human analyte panel
The Human Cytokine Magnetic 25-Plex Panel for the Luminex™ platform provides reagents for the accurate, reproducible, and sensitive quantitation of human proteins including:

Cytokines
GM-CSF
IFN-α
IFN-γ
IL-1β
IL-1RA
IL-2
IL-2R
IL-4
IL-5
IL-6
IL-7
IL-8
IL-10
IL-12 (p40/p70)
IL-13
IL-15
IL-17
TNF-α

Chemokines
Eotaxin
IP-10
MCP-1
MIG
MIP-1α
MIP-1β
RANTES

Luminex™ xMAP™ technology—effective and proven analytical tool
The Human Cytokine Magnetic 25-Plex Panel is based on xMAP™ technology. The use of a suspension bead-based technology enables the multiplexing capabilities of the Luminex™ assays. Magnetic microspheres are internally dyed with red and infrared fluorophores of differing intensities. Each bead is given a unique number, or bead region, allowing differentiation of one bead from another. Beads covalently bound to different antibodies can be mixed in the same assay, using a 96-well microplate format. Upon completion of the sandwich immunoassay, magnetic beads must be measured using a Luminex™ detection system (MAGPIX™, 100™/200™, or FLEXMAP 3D™). The instrument uses xPONENT™ software to distinguish bead color (analyte) and R-PE fluorescence intensity (assay signal strength) to quantify target(s).

Magnetic beads let you do more with your time
Magnetic bead-based assays use Luminex™ MagPlex magnetic microspheres. All other assay components are the same as the equivalent Luminex™ polystyrene bead-based assays providing identical quality and consistency performance. MagPlex technology takes advantage of magnetic properties to simplify assay wash steps and maximize uniformity of results. Magnetic bead-based assays also enable automation, decrease hands-on time, and increase throughput and precision. Easy-to-use protocols allow you to get your results in as little as 3.5 hours. In addition, these assays are compatible with both vacuum and magnetic wash stations and work well with the MAGPIX™ system as well as other Luminex™ xMAP™ platforms.

More validation for confidence in your results
The Human Cytokine Magnetic 25-Plex Panel has been validated using the same rigorous criteria that distinguishes Luminex™ assays from other commercially available assays. With more than 20 years of experience, our fully qualified antibodies help ensure the specificity and sensitivity of our assays. When benchmarked against the competition, our multiplex products consistently deliver excellent results. Every singleplex kit and premixed multiplex kit comes with a product insert that outlines the specifications for each marker in the assay (see documents section).

Learn more about all Invitrogen™ assays for the Luminex™ platform.
For Research Use Only. Not for use in diagnostic procedures.
規格
Assay RangeSee product documentation
Assay SensitivitySee Certificate of Analysis
Bead TypeSee product documentation
ConjugateR-PE
Detection MethodFluorescence
For Use With (Equipment)Luminex™ Instruments
FormatPreconfigured Panel
Product LineNovex
ProteinCytokine
Protein SubtypeCytokines & Receptors
Sample TypeSerum, Plasma, Cell Culture Supernatants
Shipping ConditionWet Ice
CombinabilityCombinable
Product TypeMultiplex Panel
Quantity96 Tests
Research AreaImmunology, Cytokines
SpeciesHuman
Unit SizeEach
內容物與存放
Contains premixed antibody coated capture beads, standard, premixed detector antibody, diluents, SAV concentrate, buffers, wash solution, flat bottom plate, complete protocol and lot-specific technical data sheet. Store at 2°C to 8°C.

常見問答集 (常見問題)

Which instruments are compatible with the Cytokine 25-Plex Human Panel (Cat. No. LHC009M)?

The Cytokine 25-Plex Human Panel (Cat. No. LHC0009M) is suitable for use with the Luminex Instrument platform, including the MAGPIX, LX100/200, FLEXMAP3D, and INTELLIFLEX systems. Details about the Luminex instrument platform and associated Protein and RNA assays can be found on our website by searching " Luminex Instruments".

Find additional tips, troubleshooting help, and resources within our Protein Assays and Analysis Support Center.

During my ProcartaPlex assay data analysis, I am getting a warning message that there is high bead aggregation. What should I do?

Here are possible causes and solutions for this issue:

- Check the protocol settings (make sure you select the correct DD settings).
- Check the level of sheath fluid and empty the waste.
- Before acquiring the plate, run calibration and verification beads on the Luminex instrument.

Find additional tips, troubleshooting help, and resources within our Protein Assays and Analysis Support Center.

During my ProcartaPlex assay data analysis, the beads fall below or to the lower left of their bead region on the bead map. Why is this?

Here are possible causes and solutions for this issue:

This usually indicates that the beads have been photobleached. This problem can also be caused by exposing the beads to organic solvents. Unfortunately, the assay will have to be repeated because the beads cannot be restored. The beads must be protected from light and organic solvents.
Alternatively, the instrument may be off in its measurements or you may have a calibration issue. Call the manufacturer for a service appointment.

Find additional tips, troubleshooting help, and resources within our Protein Assays and Analysis Support Center.

During my ProcartaPlex assay data analysis, beads do not appear in the region gated. What happened?

This indicates that an incorrect buffer was used for the final step. The Wash Solution provided in the kit must be used for washing the beads and the Reading Buffer should be used for resuspending the beads before loading them into the Luminex instrument. The osmolarity of the solution will impact the size of the bead, and any change in the bead size will alter detection by the instrument.

Find additional tips, troubleshooting help, and resources within our Protein Assays and Analysis Support Center.

The bead counts for all of my ProcartaPlex assay wells are erratic. What went wrong?

Here are some suggestions:

- Before acquiring the plate, run calibration and verification beads on the Luminex instrument.
- Review the instrument settings and make sure they are appropriate for the assay being run (adjustment of needle height, make sure you select the correct bead gates and the correct DD settings).
- Shake the plate before acquisition on the instrument to resuspend the beads.
- Vortex the beads for 30 sec before adding them into the plate.
- Washing: Do not forget to keep the plate for about 2 mins on the Hand-Held Magnetic Plate Washer before emptying the plate.

Find additional tips, troubleshooting help, and resources within our Protein Assays and Analysis Support Center.

引用資料與參考文獻 (11)

引用資料與參考文獻
Abstract
West African Sorghum bicolor leaf sheaths have anti-inflammatory and immune-modulating properties in vitro.
Authors:Benson KF, Beaman JL, Ou B, Okubena A, Okubena O, Jensen GS,
Journal:J Med Food
PubMed ID:23289787
'The impact of chronic inflammatory conditions on immune function is substantial, and the simultaneous application of anti-inflammatory and immune modulating modalities has potential for reducing inflammation-induced immune suppression. Sorghum-based foods, teas, beers, and extracts are used in traditional medicine, placing an importance on obtaining an increased understanding of the biological ... More
Reconstituted high-density lipoprotein modulates activation of human leukocytes.
Authors:Spirig R, Schaub A, Kropf A, Miescher S, Spycher MO, Rieben R,
Journal:
PubMed ID:23967171
'An anti-inflammatory effect of reconstituted High Density Lipoprotein (rHDL) has been demonstrated in atherosclerosis and in sepsis models. An increase of adhesion molecules as well as tissue factor expression on endothelial cells in response to inflammatory or danger signals are attenuated by the treatment with rHDL. Here we show the ... More
A genomic portrait of the genetic architecture and regulatory impact of microRNA expression in response to infection.
Authors:Siddle KJ, Deschamps M, Tailleux L, Nédélec Y, Pothlichet J, Lugo-Villarino G, Libri V, Gicquel B, Neyrolles O, Laval G, Patin E, Barreiro LB, Quintana-Murci L,
Journal:
PubMed ID:24482540
MicroRNAs (miRNAs) are critical regulators of gene expression, and their role in a wide variety of biological processes, including host antimicrobial defense, is increasingly well described. Consistent with their diverse functional effects, miRNA expression is highly context dependent and shows marked changes upon cellular activation. However, the genetic control of ... More
Characterization of monocyte-derived dendritic cells from immunosuppressed renal transplant recipients with and without squamous cell carcinomas.
Authors:Sandvik LF, Volchenkov R, Jonsson R, Appel S,
Journal:
PubMed ID:23790073
Renal transplant recipients (RTR) have a high risk of tumour development, especially cutaneous squamous cell carcinomas (SCC), due to long-term immunosuppressive therapy. RTR may develop multiple lesions over short time periods, and these are often more aggressive with a higher risk of local recurrence and metastasis resulting in increased morbidity ... More
In vitro suppression of immune responses using monocyte-derived tolerogenic dendritic cells from patients with primary Sjögren's syndrome.
Authors:Volchenkov R, Brun JG, Jonsson R, Appel S,
Journal:
PubMed ID:24025795
Therapeutic vaccination with antigen-specific tolerogenic dendritic cells (tolDC) might become a future option of individualized therapy for patients with autoimmune diseases. In this study, we tested the possibility of generating monocyte-derived tolDC from patients with primary Sjögren's syndrome (pSS). We analyzed phenotype, cytokine production and ability to suppress Ro/La-specific immune ... More